Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752777 · ClinicalTrials.gov registry record · NA
Behavioral Intervention to Enhance HIV Test/Treat
A NA study of HIV/AIDS, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT01752777: Completed NA study of HIV/AIDS, sponsored by University of Connecticut.
NCT01752777 is a NA study of HIV/AIDS that has completed, run by University of Connecticut. The registered enrollment target is 500 participants, below the 33,172-participant average among 61 other HIV/AIDS trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01752777, a NA study of HIV/AIDS, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Prevention strategies that aim to test and treat people for HIV infection are undermined by HIV treatment non-adherence and sexually transmitted co-infections (STI). The proposed study will test a theory-based behavioral intervention to reduce HIV infectiousness by simultaneously improving HIV treatment adherence and reducing sexually transmitted co-infections in people living with HIV-AIDS who use alcohol and other drugs. The intervention is delivered in a single office-based counseling session followed by 4 cell phone delivered counseling sessions in a model that will be ready for immediate dissemination to case management and clinical services for people living with HIV/AIDS in resource constrained settings.
Primary Outcome
HIV RNA viral load determined by blood plasma PCR
Conditions Studied
Interventions
- BEHAVIORAL Infectiousness Risk Reduction
- BEHAVIORAL General Health Improvement
Study Locations (1)
Georgia
- Southeast HIV/AIDS Research and Evaluation Project - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-02-01 |
| Est. Completion | 2018-02-01 |
| Phase | NA |
What the finished NCT01752777 record still lists
NCT01752777 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 33,172-participant average among 61 other HIV/AIDS trials with a reported enrollment target (98% lower).
The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Infectiousness Risk Reduction is the first listed.
NCT01752777 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01752777 about?
NCT01752777 is a clinical study titled "Behavioral Intervention to Enhance HIV Test/Treat". Prevention strategies that aim to test and treat people for HIV infection are undermined by HIV treatment non-adherence and sexually transmitted co-infections (STI). The proposed study will test a theory-based behavioral intervention to reduce HIV infectiousness by simultaneously improving HIV treat...
What is the current status of trial NCT01752777?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2012-02-01. Estimated completion is 2018-02-01.
What conditions does trial NCT01752777 study?
This clinical trial studies the following conditions: HIV/AIDS.
What interventions are being tested in trial NCT01752777?
The interventions under investigation include: Infectiousness Risk Reduction (BEHAVIORAL), General Health Improvement (BEHAVIORAL).
Who is sponsoring clinical trial NCT01752777?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01752777 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01752777's enrollment target sits among peer trials
500 9th of 61 higher than 52 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI